4,676
Views
13
CrossRef citations to date
0
Altmetric
Research Article

A mechanistic kinetic description of lactate dehydrogenase elucidating cancer diagnosis and inhibitor evaluation

, , , &
Pages 564-571 | Received 27 Oct 2016, Accepted 15 Dec 2016, Published online: 24 Jan 2017

References

  • O'Brien J, Kla KM, Hopkins IB, et al. Kinetic parameters and lactate dehydrogenase isozyme activities support possible lactate utilization by neurons. Neurochem Res 2007;32:597–607.
  • Nicholls D, Wood I, Nobbs T, et al. Dissecting the contributions of a specific side-chain interaction to folding and catalysis of Bacillus stearothermophilus lactate dehydrogenase. Eur J Biochem 1993;212:447–55.
  • Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol 2004;287:502–16.
  • Li G, Wang Z, Xu J, et al. The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis. BMC Cancer 2016;16:249.
  • Shi Y, Pinto BM. Human lactate dehydrogenase A inhibitors: a molecular dynamics investigation. PLoS One 2014;9:1.
  • Talaiezadeh A, Shahriari A, Tabandeh MR, et al. Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues. Cancer Cell Int 2015;15:1.
  • Deng H, Brewer S, Vu DM, et al. On the pathway of forming enzymatically productive ligand-protein complexes in lactate dehydrogenase. Biophys J 2008;95:804–13.
  • Zhu S, Wang J, Xie B, et al. Culture at a higher temperature mildly inhibits cancer cell growth but enhances chemotherapeutic effects by inhibiting cell-cell collaboration. PLoS One 2015;10:e0137042.
  • Tenenbaum-Bayer H, Levitzki A. The refolding of lactate dehydrogenase subunits and their assembly to the functional tetramer. Biochim Biophys Acta 1976;445:261–79.
  • Yuan C, Hu H, Xu G. Single amino-acids substitution in the N-terminal arm altered the tetramer stability of rat muscle lactate dehydrogenase A. Sci China Ser C 2001;44:576–84.
  • Monod J, Changeux JP, Jacob F. Allosteric proteins and cellular control systems. J Mol Biol 1963;6:306–29.
  • Cornish-Bowden A. Introduction: enzyme catalysis and allostery: a century of advances in molecular understanding. FEBS J 2014;281:433–4.
  • Khalilov RA, Dzhafarova AM, Dzhabrailova RN, Emirbekov EZ. Analysis of the kinetic characteristics of lactate dehydrogenase from the rat brain during ischemia and reperfusion. Neurochem J 2014;8:265–70.
  • Matoba Y, Miyasako M, Matsuo K, et al. An alternative allosteric regulation mechanism of an acidophilic L-lactate dehydrogenase from Enterococcus mundtii 15-1A. FEBS Open Bio 2014;4:834–47.
  • Taguchi H, Machida M, Matsuzawa H, Ohta T. Allosteric and kinetic properties of L-lactate dehydrogenase from Thermus caldophilus GK24, an extremely thermophilic bacterium. Agric Biol Chem 1985;49:359–65.
  • Vudriko P, Masatani T, Cao S, et al. Molecular and kinetic characterization of Babesia microti gray strain lactate dehydrogenase as a potential drug target. Drug Target Insights 2014;8:31–8.
  • Alberty RA. The relationship between Michaelis constants, maximum velocities and the equilibrium constant for an enzyme-catalyzed reaction. JACS 1953;75:1928–32.
  • Eggert MW, Byrne ME, Chambers RP. Impact of high pyruvate concentration on kinetics of rabbit muscle lactate dehydrogenase. Appl Biochem Biotechnol 2011;165:676–86.
  • Najdi T, Yang C, Shapiro B, et al. Application of a generalized MWC model for the mathematical simulation of metabolic pathways regulated by allosteric enzymes. J Bioinform Comput Biol 2006;4:335–55.
  • Brown WM, Yowell CA, Hoard A, et al. Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites. Biochem 2004;43:6219–29.
  • Cook WJ, Senkovich O, Hernandez A, et al. Biochemical and structural characterization of Cryptosporidium parvum Lactate dehydrogenase. Int J Biol Macromol 2015;74:608–19.
  • Jedrzejewski PM, del Val IJ, Constantinou A, et al. Towards controlling the glycoform: a model framework linking extracellular metabolites to antibody glycosylation. Int J Mol Sci 2014;15:4492–522.
  • Vesell E. Lactate dehydrogenase isozymes: substrate inhibition in various human tissues. Science 1965;150:1590–3.
  • Gubernieva LM, Safronova EE, Malakhov VN. Some kinetic properties of human lactate dehydrogenase isoenzymes. Biochemistry (Moscow) 1975;39:1030–3.
  • Chen W-Y, Huang H-M, Lin C-C, et al. Effect of temperature on hydrophobic interaction between proteins and hydrophobic adsorbents: studies by isothermal titration calorimetry and the van't Hoff equation. Langmuir 2003;19:9395–403.
  • Forouzanfar MH. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:2287–323.
  • Wan XB, Wei L, Li H, et al. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma. Eur J Cancer 2013;49:2356–64.
  • Serganova I, Rizwan A, Ni X, et al. Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype. Clin Cancer Res 2011;17:6250–61.
  • Motzer RJ, Escudier B, Bukowski R, et al. Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma. Br J Cancer 2013;108:2470–7.
  • Ahn WS, Antoniewicz MR. Towards dynamic metabolic flux analysis in CHO cell cultures. Biotechnol J 2012;7:61–74.
  • Schmid G, Blanch HW. Extra- and intracellular metabolite concentrations for murine hybridoma cells. Appl Microbiol Biotechnol 1992;36:621–5.
  • Dragowska WH, Ginj M, Kozlowski P, et al. Overexpression of HER-2 in MDA-MB-435/LCC6 tumours is associated with higher metabolic activity and lower energy stress. Sci Rep 2016;6:18537.
  • Andersen KF, Fuglo HM, Rasmussen SH, et al. Semi-quantitative calculations of primary tumor metabolic activity using F-18 FDG PET/CT as a predictor of survival in 92 patients with high-grade bone or soft tissue sarcoma. Medicine (Baltimore) 2015;94:e1142.
  • Rani R, Kumar V. Recent update on human lactate dehydrogenase enzyme 5 (hLDH5) inhibitors: a promising approach for cancer chemotherapy. J Med Chem 2016;59:487–96.
  • Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011;11:325–37.
  • Fiume L, Manerba M, Vettraino M, Di Stefano G. Inhibition of lactate dehydrogenase activity as an approach to cancer therapy. Future Med Chem 2014;6:429–45.
  • Rodriguez-Paez L, Chena-Taboada MA, Cabrera-Hernandez A, et al. Oxamic acid analogues as LDH-C4-specific competitive inhibitors. J Enzyme Inhib Med Chem 2011;26:579–86.
  • Huang C-Y, Kuo W-T, Huang Y-C, et al. Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell Death Dis 2013;4:e622.